NEW CONCEPTS IN DRUG DISCOVERY AND DEVELOPMENT

Stopping or Reversing Disease Progression

Learn More
WE ARE ENDECE

ENDECE, LLC is a privately held biopharmaceutical company at the forefront of new drug discovery and development. Our library of proprietary compounds, invented and owned by ENDECE, was designed to stop disease by up-regulating specific biological pathways to stimulate a specific biological response. We focus on diseases whose treatment options are limited or non-existent and whose causes may not be well understood including multiple sclerosis (MS) and Alzheimer’s disease.

ENDECE was founded in 2006 and is headquartered in Mequon, Wisconsin.

Learn More

LATEST NEWS

View All

ENDECE Opens San Francisco Office

ENDECE, LLC announced that it is opening an office in San Francisco, establishing a West Coast presence that reinforces its commitment to advancing its pipeline of novel therapeutics for multiple sclerosis (MS) and other neurodegenerative diseases.

read more

STRUCTURALLY SIMILAR ESTRADIOL ANALOGS UNIQUELY ALTER THE REGULATION OF INTRACELLULAR SIGNALING PATHWAYS.